Julg, Boris http://orcid.org/0000-0002-4687-9626
Stephenson, Kathryn E. http://orcid.org/0000-0002-3440-4105
Tomaka, Frank
Walsh, Stephen R. http://orcid.org/0000-0002-0817-9370
Sabrina Tan, C. http://orcid.org/0000-0001-7604-0824
Lavreys, Ludo
Sarnecki, Michal http://orcid.org/0000-0001-7035-0020
Ansel, Jessica L.
Kanjilal, Diane G. http://orcid.org/0000-0001-7300-5556
Jaegle, Kate
Speidel, Tessa
Nkolola, Joseph P.
Borducchi, Erica N.
Braams, Esmee
Pattacini, Laura
Burgess, Eleanor
Ilan, Shlomi
Bartsch, Yannic http://orcid.org/0000-0002-3844-3056
Yanosick, Katherine E.
Seaman, Michael S.
Stieh, Daniel J. http://orcid.org/0009-0003-8523-1528
van Duijn, Janine http://orcid.org/0000-0002-5097-0713
Willems, Wouter
Robb, Merlin L.
Michael, Nelson L. http://orcid.org/0000-0001-5882-5548
Walker, Bruce D.
Pau, Maria Grazia
Schuitemaker, Hanneke http://orcid.org/0000-0001-8563-2266
Barouch, Dan H. http://orcid.org/0000-0001-5127-4659
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI138790, AI149670, AI169615, AI128751, AI164556, AI177687)
Ragon Institute of MGH, MIT and Harvard (Internal grant)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 12 May 2023
Accepted: 17 April 2024
First Online: 23 May 2024
Competing interests
: D.H.B. has received grant funding from Janssen Vaccines & Prevention. B.V. and D.H.B. is a coinventor on HIV-1 vaccine antigen patents that have been licensed to Janssen Vaccines & Prevention. B.V., F.T., M.S., E.B., L.P., D.J.S., J.D., W.W., M.G.P., and H.S. are/were employees of Janssen, pharmaceutical companies of Johnson & Johnson. L.L. is a consultant to Janssen, pharmaceutical companies of Johnson & Johnson. S.R.W. has received institutional grants or contracts from Sanofi Pasteur, Janssen Vaccines/Johnson & Johnson, Moderna, Pfizer, Vir Biotechnology, and Worcester HIV Vaccine; has participated on data safety monitoring or advisory boards for Janssen Vaccines/Johnson & Johnson; and his spouse holds stock/stock options in Regeneron Pharmaceuticals. B.J. is an employee and equity holder of Leyden Laboratories B.V., a company developing respiratory virus prevention therapeutics and his spouse is an employee of and holds stock/stock options in Moderna Inc. All other authors declare no competing interests.